| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f3166d2820b5872ab84d235e5fae1d45 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D207-333
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D207-325 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D207-325
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D207-333 |
| filingDate |
2014-08-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2018-04-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_77918e1639ae4c4d7baa146e6af7c424
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a52a9dd6488bd30ba3890c2aef0045b5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6a3e01d2cbb89c8e52927c19e7692550
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eb1cec095e38829682b267b84000d2ee |
| publicationDate |
2018-04-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-9951009-B2 |
| titleOfInvention |
Polymorphic form of pyrrole derivative and intermediate thereof |
| abstract |
The present invention relates to Saroglitazar free acid of Formula (IA) or its pharmaceutically acceptable salts, pharmaceutically acceptable solvates, pharmaceutically acceptable esters, stereoisomers, tautomers, analogs and derivatives thereof. The present invention also provides an amorphous form of saroglitazar free acid and processes of preparation thereof. The present invention also provides pharmaceutical composition comprising an amorphous form saroglitazar magnesium. |
| priorityDate |
2013-08-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |